Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
Subscribe now
Kramer Levin represented the initial purchasers in connection with a $292 million securitization of life sciences and technology loans. The transaction closed on September 3, 2020.
Managing Partner, Finance and Restructuring, US and Head of Securitization, US, New York
Partner, New York
Partner, Head of Tax, US, New York
Partner, Head of Executive Compensation and Employee Benefits, US, New York
Special Counsel, New York
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead